Christopher J. Ott

6.8k citations
46 papers · 2.9k · 1 hit paper · h-index 20

Impact in

  • Hematology top 1%
    • Multiple Myeloma Research and Treatments
    • Protein Degradation and Inhibitors
    • Ubiquitin and proteasome pathways
    • Histone Deacetylase Inhibitors Research
    • Genomics and Chromatin Dynamics
    • Epigenetics and DNA Methylation

Papers in

    • Protein Degradation and Inhibitors 22
    • Genomics and Chromatin Dynamics 12
    • Ubiquitin and proteasome pathways 10
    • Histone Deacetylase Inhibitors Research 8
    • Advanced biosensing and bioanalysis techniques 5
    • Epigenetics and DNA Methylation 5
    • Multiple Myeloma Research and Treatments 10

Christopher J. Ott

43 papers receiving 2.9k citations

Christopher J. Ott's Hit Papers

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins 2013 · 1.1k citations
1.1k0+4+8Years since publication2505007501000

Peers

Christopher J. Ott
Comparison fields: 5 of 87
  • Hematology 903
  • Molecular Biology 2.4k
  • Oncology 772
  • Genetics 157
  • Immunology 303
Replace Péter Sandy with:
Péter Sandy United States
Katharina Blatt Austria
Stefan Glaser Australia
Madhavi Bandi United States
Raluca Verona United States
Jason S. Damiano United States
Matty Verlaan–de Vries Netherlands
Anastasios Karadimitris United Kingdom
Donatella Venturelli Italy
Robert K. Slany Germany
Christopher J. Ott relative to Péter Sandy United States Péter Sandy's profile →
Citations per field
00.5×2.8×
Péter Sandy · 1×
Citations per year

Countries citing papers authored by Christopher J. Ott

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Ott more than expected).

Fields of papers citing papers by Christopher J. Ott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Ott. The network helps show where Christopher J. Ott may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher J. Ott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher J. Ott Line = papers co-authored together Christopher J. Ott links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Hit paper breakdown →
20131108
2 2012294
3 2017238
4 2018167
5 2004134
6 2015113
7 2021102
8 200988
9 201875
10 201770
11 201661
12 200858
13 200951
14 201748
15 201835
16 201133
17 200524
18 201123
19 200923
20 200821

About Christopher J. Ott

Christopher J. Ott is a scholar working on Molecular Biology, Hematology, Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 46 papers that have together received 2.9k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (22 papers), Genomics and Chromatin Dynamics (12 papers), Multiple Myeloma Research and Treatments (10 papers), Ubiquitin and proteasome pathways (10 papers), Cystic Fibrosis Research Advances (8 papers), Histone Deacetylase Inhibitors Research (8 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Hematology (903 citations), Molecular Biology (2.4k citations), Oncology (772 citations), Genetics (157 citations) and Immunology (303 citations). Christopher J. Ott has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include James E. Bradner, Huahang Sun, Constantine S. Mitsiades, Gang Lu, Kwok‐Kin Wong, William G. Kaelin, Richard E. Middleton, Ann Harris, Jake Shortt and Ricky W. Johnstone. Their work appears in journals such as Blood, Nucleic Acids Research, Nature reviews. Cancer, Cell Reports and Nature Chemical Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact